Application of monoclonal antibodies directed against the COOH-terminal domain of GRP78 also shows a pro-apoptotic activity (via upregulation of p53) in 1-LN and DY145 prostate cancer cells and A375 melanoma cells [116]. Here, HSPA5 is linked to prostate carcinoma.